Specific
Antibodies against Recombinant MSP1 of Plasmodium falciparum Strongly
Inhibit the Parasite Growth in vitro
ZHANG Dong-Mei2, PAN Wei-Qing1*,
LU De-Ru2
( 1Department of Etiological Biology and 2Institute
of Medical Biotechnology & Molecular Genetics of Second Military Medical
University, Shanghai 200433,China )
Abstract In order to
produce large amounts of protein for vaccine trials,a synthetic msp1-42
gene was inserted into Pichia pastoris expression vector and the plasmid
was introduced into Pichia pastoris SMD1168 by electroporation.The
expressed MSP1-42 was secreted into the protein-free medium.To measure the conformational
properties of MSP1-42,16 monoclonal antibodies (11 recognizing conformational
epitopes) were allowed to interact with the Pichia-derived
MSP1-42, and all antibodies specific for conserved and K1 protype interacted
with the protein. Interestingly, three monoclonal antibodies (e.g. 9.8, 13.1
and 7.3), that were shown not to interact with CHO-derived MSP1, could interact
with the Pichia-derived MSP1-42. Rabbits were immunized with recombinant
MSP1-42 formulated with CFA adjuvant four times.The rabbits were bled on the
day 3 after last immunization, and total IgG isolated by protein A column from
the immunized rabbits was shown to strongly inhibit the parasite growth in
vitro dose-dependently, whereas IgG from rabbit with adjuvant had no
inhibition.
Key words Plasmodium falciparum; merozoite
surface protein 1 (MSP1); Pichia pastoris; in vitro inhibit assay
*Corresponding author: Tel,
86-21-25070934; Fax, 86-21-25070250; e-mail,
[email protected]